Evidence map›Paper›PMID 34524714›Full record

ArticleHead & neck2021

Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study.

Albert Prats-Uribe, Marc Tobed, José Miguel Villacampa, Adriana Agüero, Clara García-Bastida, José Ignacio Tato, Laura Rodrigáñez, Victoria Duque Holguera, Estefanía Hernández-García, Daniel Poletti and 14 more

Abstract readMulticenter Study
In one paragraph

Article in Head & neck, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Early versus late tracheostomy in critically ill COVID-19 patients.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Albert Prats-UribePharmaco and Device Epidemiology, Centre for Statistics in Medicine - Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, UK.ORCID 0000-0003-1202-9153
Marc TobedOtorhinolaryngology Department, Hospital Josep Trueta, Girona, Spain.
José Miguel VillacampaOtorhinolaryngology Department, Fundación Jiménez Díaz, Madrid, Spain.
Adriana AgüeroOtorhinolaryngology Department, Hospital General de Catalunya, Sant Cugat, Spain.
Clara García-BastidaOtorhinolaryngology Department, Hospital Rey Juan Carlos, Madrid, Spain.
José Ignacio TatoOtorhinolaryngology Department, Hospital Príncipe de Asturias, Alcalá de Henares, Spain.
Laura RodrigáñezOtorhinolaryngology Department, Hospital Universitario de La Paz, Madrid, Spain.
Victoria Duque HolgueraOtorhinolaryngology Department, Hospital Clínico de Valladolid, Valladolid, Spain.
Estefanía Hernández-GarcíaOtorhinolaryngology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID 0000-0002-6291-3249
Daniel PolettiOtorhinolaryngology Department, Hospital Gregorio Marañón, Madrid, Spain.
Gabriela SimonettiOtorhinolaryngology Department, Mútua de Terrassa, Terrassa, Spain.
Vanessa VillarragaOtorhinolaryngology Department, Fundació Althaia, Manresa, Spain.
Carla Meler-ClaramonteOtorhinolaryngology Department, Hospital Universitari Joan XXIII, Tarragona, Spain.
Álvaro Sánchez BarruecoOtorhinolaryngology Department, Hospital Universitario General de Villalba, Madrid, Spain.ORCID 0000-0002-7919-5765
Carlos Chiesa-EstombaOtorhinolaryngology Department, Hospital de Donosti, Donosti, Spain.ORCID 0000-0001-9454-9464
Maria CasasayasOtorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0003-4183-5832
Pablo Parente-AriasOtorhinolaryngology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
Nieves Mata-CastroOtorhinolaryngology Department, Hospital de Torrejón, Madrid, Spain.
Jordi RelloClin Research/epidemiol In Pneumonia & Sepsis (CRIPS)- Vall d'Hebrón Institute of Research (VHIR), Barcelona, Spain.
Pedro CastroMedical Intensive Care Unit, Hospital Clínic de Barcelona, UB, IDIBAPS, Barcelona, Spain.
Daniel Prieto-AlhambraPharmaco and Device Epidemiology, Centre for Statistics in Medicine - Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, UK.
Isabel VilasecaOtorhinolaryngology Department, Hospital Clínic de Barcelona, UB, IDIBAPS, Barcelona, Spain.ORCID 0000-0003-4399-5522
Francesc Xavier Avilés-JuradoOtorhinolaryngology Department, Hospital Clínic de Barcelona, UB, IDIBAPS, Barcelona, Spain.ORCID 0000-0001-5560-8097
TraqueoCOVID SEORL Group

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR 2017-SGR-01581Fundación Alfonso Martín Escudero and the Medical Research Council MR/K501256/1Fundación Alfonso Martín Escudero and the Medical Research Council MR/N013468/1National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)NIHR Senior Research Fellowship SRF-2018-11-ST2-004
6 · The paper itself

Abstract

backgroundOptimal timing for tracheotomy for critically ill COVID-19 patients requiring invasive mechanical ventilation (IMV) is not established.

methodsMulticenter prospective cohort including all COVID-19 patients admitted to intensive care units (ICUs) in 36 hospitals who required tracheotomy during first pandemic wave. With a target emulation trial framework, we studied the causal effects of early (7-10 days) versus late (>10 days) tracheotomy (LT) on time from tracheotomy to weaning, postoperative mortality, and tracheotomy complications.

resultsOf 696 patients, 20.4% received early tracheotomy (ET). ET was associated with faster weaning (hazard ratio [HR] [95% confidence interval, CI]: 1.25 [1.00-1.56]) without differences in mortality (HR [95% CI]: 0.85 [0.60-1.21]) or complications (adjusted rate ratio [95% CI]: 0.56 [0.23-1.33]).

conclusionsET had a similar or lower post-tracheotomy weaning time than LT, potentially shortening IMV and ICU stays, without changing complication or mortality rates in COVID-19 patients.

Indexed as

COVID-19Respiration, ArtificialCritical CareHumansIntensive Care UnitsProspective StudiesSARS-CoV-2Tracheotomycomplicationsintensive carerespiratory failureSARS-CoV-2weaning

Identifiers

PMID34524714
PMCPMC8652734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.